Login / Signup

New Application of cyclo Saligenyl Prodrugs Approach for the Delivery of Fosfoxacin Derivatives in Mycobacteria.

Mathilde MunierDenis TritschDidier LièvremontMichel RohmerCatherine Grosdemange-Billiard
Published in: Molecules (Basel, Switzerland) (2023)
In this work, we implemented for the first time the cyclo Saligenyl prodrug strategy to increase the bioavailability of fosmidomycin phosphate analogs in bacteria. Here, we report the synthesis of 34 cyclo Saligenyl prodrugs of fosfoxacin and its derivatives. Among them, fifteen double prodrugs efficiently prevented the growth of the non-pathogenic, fast-growing Mycobacterium smegmatis .
Keyphrases
  • mycobacterium tuberculosis
  • structure activity relationship
  • cancer therapy
  • drug release
  • molecular dynamics simulations